DJIA 16,853.72 -189.18 -1.11%
NASDAQ 4,442.69 -50.70 -1.13%
S&P 500 1,956.54 -15.75 -0.80%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

European Stocks, Pound Rise After Scots Reject Independence

China fines GSK $490 million, sentences exec over bribery

China fines GlaxoSmithKline nearly $500 million for bribery

GlaxoSmithKline convicted of bribery in China, ordered to pay half billion fine

Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog

After Hours Most Active for Sep 17, 2014 : GSK, QQQ, BAC, PSX, KORS, SQNM, FOXA, INTC, PIR, RFMD, P

After Hours Most Active for Sep 17, 2014 : GSK, QQQ, BAC, PSX, KORS, SQNM, FOXA, INTC, PIR, RFMD, PLCM, MHK

Could GlaxoSmithKline Be A Better Investment Than Gilead?

Why Sarepta Therapeutics Inc. Stock Soared By 17% in 2014

Sarepta Therapeutics stock has been whipsawed over the past year. Find out what's been the cause of its volatility and whether or not the stock can head higher.

Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)

Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

See More Articles...